Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Marek Lommatzsch^{1

2}, Kai Bratke¹, Paul Stoll¹

Affiliations

Comment

Marek Lommatzsch et al. N Engl J Med. 2018.

. 2018 Aug 30;379(9):e14.

doi: 10.1056/NEJMc1808251.

Marek Lommatzsch^{1

2}, Kai Bratke¹, Paul Stoll¹

No abstract available

Comment in

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Forde PM, Chaft JE, Pardoll DM. Forde PM, et al. N Engl J Med. 2018 Aug 30;379(9):e14. doi: 10.1056/NEJMc1808251. N Engl J Med. 2018. PMID: 30157404 No abstract available.

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, Zahurak M, Yang SC, Jones DR, Broderick S, Battafarano RJ, Velez MJ, Rekhtman N, Olah Z, Naidoo J, Marrone KA, Verde F, Guo H, Zhang J, Caushi JX, Chan HY, Sidhom JW, Scharpf RB, White J, Gabrielson E, Wang H, Rosner GL, Rusch V, Wolchok JD, Merghoub T, Taube JM, Velculescu VE, Topalian SL, Brahmer JR, Pardoll DM. Forde PM, et al. N Engl J Med. 2018 May 24;378(21):1976-1986. doi: 10.1056/NEJMoa1716078. Epub 2018 Apr 16. N Engl J Med. 2018. PMID: 29658848 Free PMC article. Clinical Trial.